Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.699
-0.010 (-1.41%)
Nov 21, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Employees
Cyclo Therapeutics had 8 employees as of December 31, 2023. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
$108,841
Profits / Employee
-$3,099,959
Market Cap
20.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
Femasys | 34 |
American Shared Hospital Services | 31 |
Spruce Biosciences | 29 |
MEI Pharma | 28 |
Pulmatrix | 22 |
Unity Biotechnology | 19 |
Akari Therapeutics, | 12 |
CYTH News
- 15 hours ago - Niemann-Pick Disease Pipeline Market Research 2024: Comprehensive Insights about 12+ Drugs Featuring Cyclo Therapeutics, Azafaros, IntraBio - GlobeNewsWire
- 7 days ago - Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) - Business Wire
- 3 months ago - CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH - Business Wire
- 3 months ago - Accession Risk Management Group Closes $1 Billion Financing to Further Accelerate Growth of Risk Strategies and One80 Intermediaries - Business Wire
- 3 months ago - Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement - Business Wire
- 3 months ago - Cyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 4 months ago - Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer's Disease from European Patent Office - Business Wire